 |
Great Debates in RVO Therapy
By: Frank Celia, Contributing Editor
An anti-VEGF and steroid gain FDA sanction, but many clinical questions remain
|
A Brave New World
By: Pravin U. Dugel, MD; Ram Palanki, PharmD; Kuo Bianchini Tong, MS
The retina subspecialty is in the vanguard of changes to clinical practice and reimbursement
|
Case Report
By: Kevin K. Suk, MD; Audina M. Berrocal, MD; Timothy G. Murray, MD, MBA; Ditte Hess, CRA
Intravitreal Bevacizumab in a Silicone-filled Eye
|
Subspecialty News
Small study jumps the gun on CATT; Data on PDT/Lucentis combinations; Radiation as a supplement to Anti-VEGF; and more
|
Controversies in Care
By: Michael Colucciello, MD
Avastin vs Lucentis for the treatment of neovascular AMD
|
Journal Club
By: Andrew E. Mathis, PhD, Medical Editor
Studies to stimulate discussion and debate
|
Coding Q & A
By: Riva Lee Asbell
Audit-causing issues in the retina practice
|
Focus On
By: Jack Persico, Executive Editor
The InVitria injection assistant
|
|
Current Issue: July 2010
|
|
 |